₩7270.00
₩0.00 (0.00%)
End-of-day quote: 05/18/2024
KOSDAQ:A095700

Genexine Annual Report

Year Year 2023 2022 2020 2019 2018 2017 2016 2014
Rev. Revenue
₩4.43B ₩16.14B ₩18.54B ₩11.30B ₩0.00M ₩0.00M ₩0.00M ₩0.00M
GM % Gross Margin %
6.82% 69.70% 52.63% 59.27% 0.00% 0.00% 0.00% 0.00%
OM Operating Margin
0.00% -208.69% -211.13% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share
₩0.00 ₩-967.00 ₩-443.00 ₩671.54 ₩-595.38 ₩-1288.46 ₩-808.46 ₩-1197.69 ₩-400.77
Div. Dividends
₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00
PR % Payout Ratio %
0 0 0.00% -0.00% 0 0 0 0
Sha. Shares
41.45m 32.69m 24.7m 23.76m 20.43m 19.85m 17.79m 14.76m
OCF Operating Cash Flow
₩-38054.51M ₩-39799.59M ₩-22690.96M ₩-41571.71M ₩0.00M ₩0.00M ₩0.00M ₩0.00M
FCF Free Cash Flow
₩-58430.96M ₩-71546.63M ₩-44898.73M ₩-45533.23M ₩-27930.09M ₩-46480.90M ₩0.00M ₩0.00M
FCFS Free Cash Flow Per Share
₩-1122.45 ₩-2186.84 ₩-1950.67 ₩-2187.20 ₩0.00 ₩0.00 ₩0.00 ₩0.00